Find clinical trials for Triple Negative Breast Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near New York, NY, USA:
Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatme ...
Phase 1
New York, New York, United States and 2 other locations
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...
Phase 2
Stamford, Connecticut, United States and 9 other locations
pelareorep and to see how well they work in treating patients with triple negative breast cancer that has spread ...
Phase 2
New Brunswick, New Jersey, United States and 1 other location
inhibitor as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study...
Phase 1
New York, New York, United States and 4 other locations
the feasibility of 1 year of adjuvant enzalutamide, an androgen receptor (AR) antagonist for the treatment of patients with early stage, AR(+) triple...
Phase 2
New York, New York, United States and 11 other locations
of carboplatin and everolimus for the treatment of advanced triple-negative breast cancer (TNBC).Study close to a...
Phase 2
New York, New York, United States and 2 other locations
This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...
Phase 2
Berkeley Heights, New Jersey, United States and 12 other locations
maximum tolerated dose (MTD) of OTS167 administered via oral capsule (PO) to patients with relapsed/refractory locally advanced or metastatic breast...
Phase 1
New York, New York, United States and 3 other locations
a study drug called Rucaparib, administered in combination with the type of radiation therapy that is usually given to women with your form of breast...
Phase 1
New York, New York, United States and 7 other locations
This pilot study will provide preliminary data regarding the role of PIS in predicting the benefit of immune checkpoint inhibition with or without ch...
Phase 2
Hackensack, New Jersey, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal